The role of aspirin resistance in the treatment of acute coronary syndromes (Q28221026)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

review article

1 reference

title

The role of aspirin resistance in the treatment of acute coronary syndromes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

acute coronary syndrome

1 reference

Gilead I Lancaster

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

Hitender Jain

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

Stuart W Zarich

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

language of work or name

English

0 references

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

volume

31

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

page(s)

11-17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

Toward a new frontier in myocardial reperfusion therapy: emerging platelet preeminence

5 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1002/CLC.20157

Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy

21 January 2018

1 reference

12 December 2020

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

1 reference

12 December 2020

Prior aspirin users with acute non-ST-elevation coronary syndromes are at increased risk of cardiac events and benefit from enoxaparin

1 reference

12 December 2020

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

1 reference

12 December 2020

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

12 December 2020

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

12 December 2020

Prior aspirin use in unstable angina predisposes to higher risk: the aspirin paradox

1 reference

12 December 2020

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

1 reference

12 December 2020

ACC/AHA Guideline Update for the Management of Patients With Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction--2002: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice G

1 reference

12 December 2020

Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate

1 reference

12 December 2020

Aspirin non-responder status in patients with recurrent cerebral ischemic attacks

1 reference

12 December 2020

Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatide

1 reference

12 December 2020

Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease

1 reference

12 December 2020

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

1 reference

12 December 2020

ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction. ISIS-3 (Third International Study of Infarct S

1 reference

12 December 2020

Incidence of aspirin nonresponsiveness using the Ultegra Rapid Platelet Function Assay-ASA

1 reference

12 December 2020

Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment

1 reference

12 December 2020

Assessing aspirin responsiveness in subjects with multiple risk factors for vascular disease with a rapid platelet function analyzer

1 reference

12 December 2020

Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction

1 reference

12 December 2020

Aspirin resistance: position paper of the Working Group on Aspirin Resistance

1 reference

12 December 2020

Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different?

1 reference

12 December 2020

High frequency of aspirin resistance in patients with acute coronary syndrome

1 reference

12 December 2020

Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes

1 reference

12 December 2020

Aspirin resistance and atherothrombotic disease

1 reference

12 December 2020

Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation

1 reference

12 December 2020

Aspirin to prevent heart attack and stroke: what's the right dose?

1 reference

12 December 2020

Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

1 reference

12 December 2020

Aspirin resistance: is it real? Is it clinically significant?

1 reference

12 December 2020

Use of Heparins in Non-ST-Elevation Acute Coronary Syndromes

1 reference

12 December 2020

Angioscopic Evaluation of Coronary-Artery Thrombi in Acute Coronary Syndromes

1 reference

12 December 2020

Unstable angina or non-Q wave infarction despite long-term aspirin: response to thrombolytic therapy with implications on mechanisms

1 reference

12 December 2020

Aspirin, heparin, or both to treat acute unstable angina

1 reference

12 December 2020

Previous Aspirin Use May Attenuate the Severity of the Manifestation of Acute Ischemic Syndromes

1 reference

12 December 2020

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

12 December 2020

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

1 reference

12 December 2020

Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group

1 reference

12 December 2020

Thrombosis in ischemic heart disease

1 reference

12 December 2020

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

1 reference

12 December 2020

Pathophysiology and initial management of the acute coronary syndromes

1 reference

12 December 2020

The platelet proaggregating and potentiating effects of unfractionated heparin, low molecular weight heparin and heparinoid in intensive care patients and healthy controls.

1 reference

12 December 2020

A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group

1 reference

12 December 2020

Dissolution of Mural Thrombus by Specific Thrombin Inhibition With r-Hirudin

1 reference

12 December 2020

Effects of prior aspirin and anti-ischemic therapy on outcome of patients with unstable angina. TIMI 7 Investigators. Thrombin Inhibition in Myocardial Ischemia

1 reference

12 December 2020

Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction

1 reference

12 December 2020

Contemporary evaluation and management of hypertrophic cardiomyopathy

1 reference

Crossref

https://api.crossref.org/works/10.1002/CLC.20157

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CLC.20157

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

release_6fuzlvwohzbxnpwz2je52upsre

5 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6fuzlvwohzbxnpwz2je52upsre

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17803242 AND SRC:MED&resulttype=core&format=json

5 January 2020

PubMed publication ID

17803242

1 reference